91Ó°ÊÓ

An inactive enzyme precursor is often referred to as a zymogen.
Zymogens are produced by the body to regulate enzymes.
Enzymes are proteins that catalyze biochemical reactions.
In their inactive form, zymogens cannot catalyze any reaction.
This mechanism prevents unwanted reactions from occurring inside the body.
For instance, digestive enzymes are produced in an inactive form.
If they were active, they could damage the cells that produce them.
Zymogens are specifically activated when required. This way, they only function in the right place and at the right time.

Peptide bond cleavage is a critical step in zymogen activation.
Peptide bonds are the chemical linkages between amino acids in a protein.
Cleaving specific peptide bonds can change the structure of the protein.
When a zymogen’s peptide bond is cleaved, it often unfolds and assumes an active shape.
This structural change is what turns the zymogen into an active enzyme.
The process is highly specific; only particular bonds are targeted for cleavage.
Enzymes or physical conditions like pH changes or temperature shifts can cause this cleavage.

Proteolytic activation is the process of converting a zymogen to an active enzyme.
It involves the cleavage of protein chains by other enzymes called proteases.
This process is irreversible and highly regulated.
One common example is the digestive enzyme trypsin, which starts as the zymogen trypsinogen.
The zymogen is activated when it reaches the intestine, ensuring it does not digest cellular proteins prematurely.
Blood clotting is another area where proteolytic activation is essential.
Many of the proteins involved in coagulation are initially inactive zymogens.
They activate in a controlled sequence to form a blood clot.
Proteolytic activation is fundamental for regulating pivotal physiological processes.